A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclerosis (RRMS) with Disease Activity on Prior Disease Modifying Therapy (DMT)

The requested reference [d154890cd9bf906856d548ffd472a5fbb6559730] no longer exists in our database. It has been replaced by the current reference: [389e7887e47a2fd0ff215abe09cc2195b198ca4b]

Authors
Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2019
This article has no abstract
Epistemonikos ID: d18172166dd3f2472da15cd04652ff8dc3f1de3e
First added on: Apr 11, 2025